Targeted sequencing of the LRRTM gene family in suicide attempters with bipolar disorder

Abstract

Glutamatergic signaling is the primary excitatory neurotransmission pathway in the brain, and its relationship to neuropsychiatric disorders is of considerable interest. Our previous attempted suicide genome-wide association study, and numerous studies investigating gene expression, genetic variation, and DNA methylation have implicated aberrant glutamatergic signaling in suicide risk. The glutamatergic pathway gene LRRTM4 was an associated gene identified in our attempted suicide genome-wide association study, with association support seen primarily in females. Recent evidence has also shown that glutamatergic signaling is partly regulated by sex-related hormones.The LRRTM gene family encodes neuronal leucine-rich transmembrane proteins that localize to and promote glutamatergic synapse development. In this study, we sequenced the coding and regulatory regions of all four LRRTM gene members plus a large intronic region of LRRTM4 in 476 bipolar disorder suicide attempters and 473 bipolar disorder nonattempters. We identified two male-specific variants, one female-and five male-specific haplotypes significantly associated with attempted suicide in LRRTM4. Furthermore, variants within significant haplotypes may be brain expression quantitative trait loci for LRRTM4 and some of these variants overlap with predicted hormone response elements. Overall, these results provide supporting evidence for a sex-specific association of genetic variation in LRRTM4 with attempted suicide. K E Y W O R D Sglutamatergic signaling, haplotype, LRRTM4, sex specificity, suicidal behavior

Gene Module Analysis Reveals Cell-Type Specificity and Potential Target Genes in Autism’s Pathogenesis

“…Original LRRTM4 contains multiple hormonal response parts (HREs). Variations within these HREs may alter the binding and activation of different hormone receptors, leading to an increased risk of mental disease [ 31 ]. LRRTM4 is essential for brain synaptic production activity.…”

“…The functions of these five genes cover synapses, neuron proliferation, protein interaction, and chemical transmission in the synapses. Their mutations and dyscontrol have also been proven to be associated with various mental disorders, including schizophrenia, ataxia, depression, and ASD [ 26 , 28 , 29 , 30 , 31 , 32 , 33 , 35 ]. When checking the association between genes and clinical severity of ASD, LINGO2 is of note, which has been verified to be linked to neurodegenerative disorders, such as essential tremor and Parkinson’s disease.…”

PACeR: a bioinformatic pipeline for the analysis of chimeric RNA-seq data

“…While the traditional view of miRNA binding to targets is that these binding sites occur within the 3’ UTR of target transcripts, there is growing evidence that miRNA-binding interactions can also occur in other regions of transcripts such as introns present in primary pre-mRNA (Sarshad et al 2018). Figure 7 represents an example of a let-7 family binding site detected in our generated chimeric RNA-seq data within an annotated intron of Lrrtm4, a gene which encodes a transsynaptic adhesion protein (Chen et al 2019; Reichman et al 2020). It should be noted that such binding sites could actually reside in exons or other transcript regions due to alternatively spliced transcripts; accompanying total mRNA-seq data could be evaluated for comparison.…”

Vitamin D and the Risks of Depression and Anxiety: An Observational Analysis and Genome-Wide Environment Interaction Study

“…The LRRTM4 is a new four-membered family of genes from human and mice. Its main function is to encode a putative leucine-rich repeat transmembrane protein, which can not only facilitate the development of glutamate synapses, but also regulate many cellular events during nervous system development and disease [54,55]. In animal experiments, it has been found that LRRTM4 is expressed in many brain regions and nervous system neurons, suggesting that LRRTM4 plays a vital role in the development and maintenance of the vertebrate nervous system [54].…”